In this light, DEFA5 immunoreactivity in colonic endoscopy biopsies could be a potential diagnostic tool to accurately diagnose CC and provide the basis for resolving the ambiguity in the diagnosis of IBD to circumvent diagnostic delay and permit timely and accurate diagnosis and prescription of appropriate treatment options, especially surgically. The gene discussed is DEFA5; the disease is inflammatory bowel disease.